News about Industrial talks

Fosun Health Capital reached a cooperation agreement with Medicilon to explore innovative drug research and development together

Fosun Health Capital reached a cooperation agreement with Medicilon to explore innovative drug research and development together

Industrial talks | 01/08/2023 | By Sudeep Soparkar |  451

Thermo Fisher Scientific Launches ARLX'TRA Companion X-ray Diffractometer that Enables High Precision Phase

The ARL X’TRA Companion X-ray Diffractometer is the latest instrument within Thermo Fisher’s well established X-ray diffraction (XRD) product line. The instrument enables rapid and comprehensive analysis of phases in a wide range of samples, from clinker to battery materials.

Industrial talks | 31/07/2023 | By Manvi |  529

IBN Sina Pharma to invest Tk10cr in API project

IBN Sina Pharma to invest Tk10cr in API project

Industrial talks | 25/07/2023 | By Sudeep Soparkar |  989

Indian pharma mulls JVs with local counterparts

Indian pharma mulls JVs with local counterparts

Industrial talks | 24/07/2023 | By Sudeep Soparkar |  372

Santen Agrees to Licensing Agreements and Asset Transfer for its Pharmaceutical Products in North America

Santen Agrees to Licensing Agreements and Asset Transfer for its Pharmaceutical Products in North America

Industrial talks | 20/07/2023 | By Sudeep Soparkar |  659

Endo Launches Bivalirudin Injection in Ready-to-Use Vials

Endo Launches Bivalirudin Injection in Ready-to-Use Vials

Industrial talks | 19/07/2023 | By Sudeep Soparkar |  621

Dr Reddys Laboratories Ltd signs for consumption of renewable energy

Dr Reddys Laboratories Ltd signs for consumption of renewable energy

Industrial talks | 17/07/2023 | By Sudeep Soparkar |  555

Himachal delegation visits Jawaharlal Nehru Pharma City (JNPC), Vizag

Himachal delegation visits Jawaharlal Nehru Pharma City (JNPC), Vizag

Industrial talks | 11/07/2023 | By Sudeep Soparkar |  813

CuraTeQ obtains exclusive rights for BioFactura's Ustekinumab biosimilar

CuraTeQ obtains exclusive rights for BioFactura's Ustekinumab biosimilar

Industrial talks | 10/07/2023 | By Sudeep Soparkar |  732

Cipla Issues Voluntary Nationwide Recall of Six batches of Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered Inhalation) due to Container Defect

Cipla Issues Voluntary Nationwide Recall of Six batches of Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered Inhalation) due to Container Defect

Industrial talks | 10/07/2023 | By Sudeep Soparkar |  734